Trusted News Discovery Since 2008
{{/content}}
No more needle pricks, oral drug for kids below 6 with TB gets approval
Credit: IndiaTimes- Published on April 11, 2024
Approval of Delamanid for children under 5 in India signifies a major leap in paediatric TB treatment, replacing injectables with severe side effects. The update brings relief to young patients, offering an all-oral regimen for drug-resistant TB.